postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy
نویسندگان
چکیده
normal 0 false false false en-us x-none ar-sa microsoftinternetexplorer4 background: to investigate the reasons for p ostvitrectomy diabetic vitreous hemorrhage (pdvh), and to analyze the time of pdvh onset, the treatment of pdvh, the visual outcome of the treatment, and factors that affect visual acuity after treatment. materials and methods: overall, 292 eyes from 236 patients with proliferative diabetic retinopathy (pdr) underwent vitrectomy from 2006 to 201 0 . fifty eyes out of 43 patients had severe postoperative vitreous hemorrhage. the average follow-up duration was 6.8 ± 3.8 months (range, 2 – 12 months). results: recurrent vitreous hemorrhage (vh) after primary vitrectomy occurred in 40 eyes (80%) with an average time of vh onset of 62.5 ± 32.8 days (range, 3 – 170 days). vh occurred after silicone oil removal occurred in 10 eyes (20%), with an average time of vh onset of 27.4 ± 20.3 days (range, 1 – 60 days). the reasons for pdvh included chronic errhysis from retinal neovessels (47.1% of the eyes), residual fibrous vascular membrane (12.8% of the eyes), fibrovascular ingrowth at sclerotomy sites (4.3% of the eyes), iris neovessels and neovascular glaucoma (4.3% of the eyes), retinal vein occlusion (2.8% of the eyes), retinal tears (8.1% of the eyes), retinotomy (1.4% of the eyes), epichoroidal bleeding (1.4% of the eyes), polycythemia rubra vera (1.4% of the eyes), hypoperfusional retinopathy (4.3% of the eyes), and unknown reasons (12.8% of the eyes). visual acuity increased in 43 eyes (86%) after surgical or nonsurgical treatment. the improvement in visual acuity after treatment was not affected by age, sex, duration of diabetes, time of pdvh onset, frequency of surgery, or treatment methods. conclusion: p ostvitrectomy diabetic vitreous hemorrhage commonly occurs two months after vitrectomy. residual epiretinal neovascularization is the most common cause of pdvh. active surgical or nonsurgical treatment for severe vitreous hemorrhage can obviously improve the patients' visual prognosis.
منابع مشابه
Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy
BACKGROUND To investigate the reasons for postvitrectomy diabetic vitreous hemorrhage (PDVH), and to analyze the time of PDVH onset, the treatment of PDVH, the visual outcome of the treatment, and factors that affect visual acuity after treatment. MATERIALS AND METHODS Overall, 292 eyes from 236 patients with proliferative diabetic retinopathy (PDR) underwent vitrectomy from 2006 to 2010. Fif...
متن کاملRaman spectroscopy of human vitreous in proliferative diabetic retinopathy.
PURPOSE Recent studies have demonstrated increased nonenzymatic glycation in vitreous from patients with diabetic retinopathy. The present study reports the use of Raman spectroscopy as a novel approach for investigating these molecular changes in human vitreous and experimental tissues. METHODS Near-infrared laser-excited Fourier-transform (FT) Raman spectroscopy (RS) was performed on vitreo...
متن کاملDifferential expression of vitreous proteins in proliferative diabetic retinopathy.
PURPOSE To identify vitreous proteins that were differentially expressed in patients suffering from proliferative diabetic retinopathy with active neovascularization. METHODS The vitreous samples of 15 active proliferative diabetic retinopathy patients were analyzed by two-dimensional gel electrophoresis and mass spectrometry, and the results were compared with those from age-matched patients...
متن کاملExternal diathermy treatment of proliferative diabetic retinopathy with vitreous haemorrhage.
Sixty-six cases of advanced proliferative diabetic retinopathy were treated by external diathermy. The eyes had extensive fibrovascular proliferations growing into the vitreous. All had some blood, recent and old, in the vitreous. The vitreous was extremely degenerated and retracted. All the patients had inadequate diabetic control. More than half were hypertensive, with reasonable medical cont...
متن کاملIntravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
PURPOSE To report the short term anatomical and visual acuity response after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. METHODS Ten eyes having proliferative diabetic retinopathy were treated with at least one intravitreal injection of bevacizumab, 1.25 mg in 0.05 mL. Patients underwent complete ophthalmologic evaluation at baseline and follow u...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
journal of research in medical sciencesجلد ۱۷، شماره ۹، صفحات ۰-۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023